Kenneth Peters

Summary

Affiliation: William Beaumont Hospital
Country: USA

Publications

  1. doi request reprint Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study
    Kenneth M Peters
    Beaumont Health System, Royal Oak, Michigan, USA
    J Urol 189:2194-201. 2013
  2. doi request reprint Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study
    Kenneth M Peters
    Department of Urology Beaumont Health System, Royal Oak, MI 48073, USA
    Neurourol Urodyn 32:24-9. 2013
  3. ncbi request reprint Frequency, urgency, and pelvic pain: treating the pelvic floor versus the epithelium
    Kenneth M Peters
    3535 West 13 Mile Road, Suite 438, Royal Oak, MI 48073, USA
    Curr Urol Rep 7:450-5. 2006
  4. ncbi request reprint A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis
    Kenneth M Peters
    Department of Urology, Ministrelli Program for Urologic Research and Education MPURE, William Beaumont Hospital, Royal Oak, Michigan, USA
    BJU Int 100:835-9. 2007
  5. ncbi request reprint Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial
    Kenneth M Peters
    Department of Urology, Ministrelli Program for Urologic Research and Education MPURE, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
    Neurourol Urodyn 24:643-7. 2005
  6. doi request reprint Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial
    Kenneth M Peters
    Department of Urology, Beaumont Hospital, Royal Oak, Michigan 48073, USA
    J Urol 183:1438-43. 2010
  7. doi request reprint Alternative approaches to sacral nerve stimulation
    Kenneth M Peters
    Department of Urology, William Beaumont Hospital, Royal Oak, MI, USA
    Int Urogynecol J 21:1559-63. 2010
  8. doi request reprint Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial
    Kenneth M Peters
    William Beaumont Hospital, Royal Oak, Michigan, USA
    J Urol 182:1055-61. 2009
  9. ncbi request reprint Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis
    K M Peters
    Department of Urology, William Beaumont Hospital, 3535 West 13 Mile Road, Suite 438, Royal Oak, Michigan, USA
    BJU Int 93:777-9. 2004
  10. ncbi request reprint Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique
    Kenneth M Peters
    Department of Urology, William Beaumont Hospital, 3535 West 13 Mile Rd, Suite 438, Royal Oak, MI 48073, USA
    Int Urogynecol J Pelvic Floor Dysfunct 14:223-8; discussion 228. 2003

Detail Information

Publications42

  1. doi request reprint Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study
    Kenneth M Peters
    Beaumont Health System, Royal Oak, Michigan, USA
    J Urol 189:2194-201. 2013
    ..We report the long-term efficacy and safety of percutaneous tibial nerve stimulation with the UrgentĀ® PC Neuromodulation System for overactive bladder after 3 years of therapy...
  2. doi request reprint Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study
    Kenneth M Peters
    Department of Urology Beaumont Health System, Royal Oak, MI 48073, USA
    Neurourol Urodyn 32:24-9. 2013
    ..To evaluate the safety, sustained effectiveness, and treatment interval for percutaneous tibial nerve stimulation (PTNS) for overactive bladder (OAB) therapy through 24 months...
  3. ncbi request reprint Frequency, urgency, and pelvic pain: treating the pelvic floor versus the epithelium
    Kenneth M Peters
    3535 West 13 Mile Road, Suite 438, Royal Oak, MI 48073, USA
    Curr Urol Rep 7:450-5. 2006
    ..Pelvic floor therapies should be a first line of treatment for those women with chronic pelvic pain related to pelvic floor dysfunction...
  4. ncbi request reprint A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis
    Kenneth M Peters
    Department of Urology, Ministrelli Program for Urologic Research and Education MPURE, William Beaumont Hospital, Royal Oak, Michigan, USA
    BJU Int 100:835-9. 2007
    ..To compare sacral nerve stimulation (SNS) with pudendal nerve stimulation (PNS) for interstitial cystitis (IC)...
  5. ncbi request reprint Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial
    Kenneth M Peters
    Department of Urology, Ministrelli Program for Urologic Research and Education MPURE, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
    Neurourol Urodyn 24:643-7. 2005
    ..The objective of the study was to compare sacral nerve stimulation (SNS) to pudendal nerve stimulation (PNS) for voiding dysfunction...
  6. doi request reprint Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial
    Kenneth M Peters
    Department of Urology, Beaumont Hospital, Royal Oak, Michigan 48073, USA
    J Urol 183:1438-43. 2010
    ..The improvement in global response assessment, voiding diary parameters, and overactive bladder and quality of life questionnaires was evaluated...
  7. doi request reprint Alternative approaches to sacral nerve stimulation
    Kenneth M Peters
    Department of Urology, William Beaumont Hospital, Royal Oak, MI, USA
    Int Urogynecol J 21:1559-63. 2010
    ..A benefit of neuromodulation is that it is minimally invasive and reversible. New sites of stimulation are being developed to add to our treatment options...
  8. doi request reprint Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial
    Kenneth M Peters
    William Beaumont Hospital, Royal Oak, Michigan, USA
    J Urol 182:1055-61. 2009
    ..The reduction in overactive bladder symptoms along with global response assessments was evaluated...
  9. ncbi request reprint Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis
    K M Peters
    Department of Urology, William Beaumont Hospital, 3535 West 13 Mile Road, Suite 438, Royal Oak, Michigan, USA
    BJU Int 93:777-9. 2004
    ..Minneapolis, MN) in treating chronic pelvic pain associated with interstitial cystitis (IC, a symptom complex of urinary urgency, frequency and pelvic pain, often necessitating narcotics) refractory to standard therapy...
  10. ncbi request reprint Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique
    Kenneth M Peters
    Department of Urology, William Beaumont Hospital, 3535 West 13 Mile Rd, Suite 438, Royal Oak, MI 48073, USA
    Int Urogynecol J Pelvic Floor Dysfunct 14:223-8; discussion 228. 2003
    ..We concluded that sacral nerve modulation can treat refractory IC symptoms. The response to therapy and the reoperation rate are dependent on the technique used to test and implant the device...
  11. ncbi request reprint Fact or fiction--is abuse prevalent in patients with interstitial cystitis? Results from a community survey and clinic population
    Kenneth M Peters
    Department of Urology, Ministrelli Program for Urologic Research and Education, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
    J Urol 178:891-5; discussion 895. 2007
    ..We determined whether abuse is associated with interstitial cystitis by surveying patients with interstitial cystitis and controls. We corroborated this association in a clinic population...
  12. ncbi request reprint Sexual function and sexual distress in women with interstitial cystitis: a case-control study
    Kenneth M Peters
    Ministrelli Program for Urologic Research and Education, Department of Urology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
    Urology 70:543-7. 2007
    ..To evaluate female sexual dysfunction (FSD) in women with interstitial cystitis (IC) versus a control group. Specific areas of FSD in women with IC have not been reported...
  13. doi request reprint Validation of a sham for percutaneous tibial nerve stimulation (PTNS)
    Kenneth Peters
    Beaumont Hospital, Department of Urology, Royal Oak, Michigan 48073, USA
    Neurourol Urodyn 28:58-61. 2009
    ..Percutaneous tibial nerve stimulation (PTNS) supposedly demonstrates 50-60% improvement in OAB symptoms with no sham-controlled trials reported. This study determined the efficacy of a sham for PTNS...
  14. ncbi request reprint Prevalence of self-reported interstitial cystitis (IC) and interstitial-cystitis-like symptoms among adult women in the community
    Ibrahim A Ibrahim
    William Beaumont Hospital, Royal Oak, MI, USA
    Int Urol Nephrol 39:489-95. 2007
    ..Reported estimates of IC prevalence vary widely. The objective of this study is to determine the prevalence of IC among community-dwelling adult women...
  15. doi request reprint Guided imagery for women with interstitial cystitis: results of a prospective, randomized controlled pilot study
    Donna J Carrico
    William Beaumont Hospital, Department of Urology, Royal Oak, MI 48073, USA
    J Altern Complement Med 14:53-60. 2008
    ..The purpose of this clinical investigation was to explore the effect of guided imagery on pelvic pain and urinary symptoms in women with IC symptoms...
  16. doi request reprint The relationship between subjective and objective assessments of sacral neuromodulation effectiveness in patients with urgency-frequency
    Kenneth M Peters
    Department of Urology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
    Neurourol Urodyn 27:775-8. 2008
    ....
  17. doi request reprint Comparison of patients undergoing a two-stage sacral nerve stimulation procedure: is there a cost benefit for a single-stage procedure?
    Dmitriy Nikolavsky
    Ministrelli Program for Urology Research and Education, Beaumont Hospital, Royal Oak, MI, USA
    Int Urol Nephrol 43:997-1002. 2011
    ..This study's purpose was to determine the overall response rate, costs of a two-staged versus single-stage approach, and explore predictors of a positive response...
  18. ncbi request reprint Dilemmas in diagnosing pelvic pain: multiple pelvic surgeries common in women with interstitial cystitis
    Michael S Ingber
    Department of Urology, Ministrelli Program for Urologic Research and Education, William Beaumont Hospital, Royal Oak, MI, USA
    Int Urogynecol J Pelvic Floor Dysfunct 19:341-5. 2008
    ..Women with IC have significantly more pelvic surgeries than controls. The majority of these surgeries were done before the diagnosis of IC and may be performed for pain related to undiagnosed IC...
  19. doi request reprint Characterization of a clinical cohort of 87 women with interstitial cystitis/painful bladder syndrome
    Kenneth M Peters
    Ministrelli Program for Urology Research and Education, Department of Urology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
    Urology 71:634-40. 2008
    ..This was reported with the National Institutes of Health chronic prostatitis cohort, but a literature review did not reveal a similar study for women with IC/PBS...
  20. doi request reprint Sacral neuromodulation reprogramming: is it an office burden?
    Frank N Burks
    Department of Urology, William Beaumont Hospital, 3535 W 13 Mile Road Suite 438, Royal Oak, MI 48073, USA
    Int Urogynecol J Pelvic Floor Dysfunct 19:1137-40. 2008
    ..These data suggest that the number of reprogramming episodes is small, and the majority is done as part of routine follow-up. No additional burden was seen in subjects with interstitial cystitis...
  21. ncbi request reprint Prevalence of pelvic floor dysfunction in patients with interstitial cystitis
    Kenneth M Peters
    Ministrelli Program for Urology Research and Education, Department of Urology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
    Urology 70:16-8. 2007
    ..To evaluate the prevalence of pelvic floor dysfunction in women with interstitial cystitis (IC)...
  22. ncbi request reprint Painful bladder syndrome/interstitial cystitis and vulvodynia: a clinical correlation
    Kenneth Peters
    Department of Urology, William Beaumont Hospital, Royal Oak, MI, USA
    Int Urogynecol J Pelvic Floor Dysfunct 19:665-9. 2008
    ..The correlation of vulvodynia and PBS/IC may have been underestimated. Research needs to explore the link between precipitating factors, symptoms, and effective treatment options for PBS/IC and vulvodynia...
  23. doi request reprint Childhood symptoms and events in women with interstitial cystitis/painful bladder syndrome
    Kenneth M Peters
    Department of Urology, Ministrelli Program for Urology Research and Education, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
    Urology 73:258-62. 2009
    ..The relationship between dysfunctional voiding and bowel symptoms in early life and the development of IC/PBS is not clear...
  24. ncbi request reprint Neuromodulation versus medication for overactive bladder: the case for early intervention
    Frank N Burks
    William Beaumont Hospital, 3535 West Thirteen Mile Road, Suite 438, Royal Oak, MI 48073, USA
    Curr Urol Rep 10:342-6. 2009
    ..Neuromodulation is a well-established treatment for "refractory" OAB that deserves a place among traditional treatments for OAB...
  25. ncbi request reprint The relationship of interstitial cystitis/painful bladder syndrome to vulvodynia
    Donna J Carrico
    The WISH Program, Department of Urology Beaumont Hospital, Royal Oak, MI, USA
    Urol Nurs 29:233-8. 2009
    ..The vulva, not the urethra or bladder, may actually be the site of some of the reported pain in women with IC/PBS...
  26. doi request reprint Randomized, double-blind, placebo-controlled trial of flexible-dose fesoterodine in subjects with overactive bladder
    Roger R Dmochowski
    Department of Urology, Vanderbilt University Medical Center, Room A 1302, Medical Center North, Nashville, TN 37232, USA
    Urology 75:62-8. 2010
    ..To evaluate the efficacy and tolerability of flexible-dose fesoterodine vs placebo in subjects with overactive bladder (OAB)...
  27. doi request reprint Neuromodulation and the neurogenic bladder
    Frank N Burks
    Department of Urology, William Beaumont Hospital, 3535 West Thirteen Mile Road, Suite 438 MOB, Royal Oak, MI 48073, USA
    Urol Clin North Am 37:559-65. 2010
    ..Neuromodulation, both electrical and physical, play an important role in the management of neurogenic bladder...
  28. ncbi request reprint Expanding indications for neuromodulation
    Andrew J Bernstein
    Department of Urology, William Beaumont Hospital, 3535 West 13 Mile Road, Suite 438, Royal Oak, MI 48073, USA
    Urol Clin North Am 32:59-63. 2005
    ..Rather, by modulating the nerves, the urologists will treat these disorders in a minimally invasive fashion and neuromodulation will become the first-line therapy before any major surgery is undertaken...
  29. doi request reprint Neuromodulation and female sexual function: does treatment for refractory voiding symptoms have an added benefit?
    Michael S Ingber
    Department of Urology, Ministrelli Program for Urology Research and Education MPURE, William Beaumont Hospital, 3535 W Thirteen Mile Rd Suite 438, Royal Oak, MI 48073, USA
    Int Urogynecol J Pelvic Floor Dysfunct 20:1055-9. 2009
    ..Women undergoing InterStim implantation for overactive bladder (OAB) or painful bladder syndrome (PBS) were prospectively evaluated to determine if neuromodulation has any effect on female sexual function (FSF)...
  30. doi request reprint Outcomes of lumbar to sacral nerve rerouting for spina bifida
    Kenneth M Peters
    Department of Urology, William Beaumont Hospital, Royal Oak, Michigan, USA
    J Urol 184:702-7. 2010
    ..We report 1-year results of the first North American trial on nerve rerouting...
  31. ncbi request reprint A referral center's experience with transitional cell carcinoma misdiagnosed as interstitial cystitis
    William D Tissot
    Department of Urology, William Beaumont Hospital, Royal Oak, Michigan, USA
    J Urol 172:478-80. 2004
    ..We present our experience with patients "labeled" as having IC who truly had cancer as the cause of irritative symptoms...
  32. ncbi request reprint Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis
    J Curtis Nickel
    Department of Urology, Queen s University, Kingston General Hospital, Kingston, Ontario, Canada
    J Urol 177:1832-6. 2007
    ..Interstitial cystitis significantly negatively impacts quality of life. The demographic and clinical factors associated with decreased quality of life in these patients have not been well studied...
  33. doi request reprint Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study
    Scott A MacDiarmid
    Alliance Urology Specialists, Greensboro, NC 27403, USA
    Mayo Clin Proc 83:1002-10. 2008
    ..To evaluate the efficacy and tolerability of extended-release oxybutynin in combination with the alpha1-blocker tamsulosin in reducing lower urinary tract symptoms in men...
  34. ncbi request reprint Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin?
    Kathleen Joy Propert
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Blockley Hall, 6th Floor, 423 Guardian Dr, Philadelphia, Pennsylvania 19104, USA
    J Urol 178:886-90. 2007
    ....
  35. ncbi request reprint Is urine methylhistamine a useful marker for interstitial cystitis?
    Deborah R Erickson
    Department of Surgery Division of Urology, Pennsylvania State University College of Medicine, Hershey, PA, USA
    J Urol 172:2256-60. 2004
    ..We determined whether urine methylhistamine (MH) is associated with other clinical features and bladder biopsy findings in interstitial cystitis (IC)...
  36. pmc Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome
    Deborah R Erickson
    Department of Surgery, Division of Urology, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0298, USA
    J Urol 179:1850-6. 2008
    ..We tested for associations between urine markers, bladder biopsy features and bladder ulcers in interstitial cystitis/painful bladder syndrome...
  37. ncbi request reprint Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis?
    Deborah R Erickson
    From the Department of Surgery, Division of Urology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA
    J Urol 173:93-7. 2005
    ....
  38. ncbi request reprint A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis
    Robert Mayer
    University of Rochester, Rochester, New York, USA
    J Urol 173:1186-91. 2005
    ..We compared intravesical bacillus Calmette-Guerin (BCG) to placebo instillations in patients with treatment refractory interstitial cystitis (IC)...
  39. pmc Changes in urine markers and symptoms after bladder distention for interstitial cystitis
    Deborah R Erickson
    Department of Surgery, Division of Urology, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0298, USA
    J Urol 177:556-60. 2007
    ..We evaluated changes in urine markers and symptom scores after bladder distention in patients with interstitial cystitis...
  40. pmc Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo
    Kathleen Joy Propert
    University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Urol 179:552-5. 2008
    ..We evaluated the longer term response in patients with interstitial cystitis who initially responded to intravesical bacillus Calmette-Guerin or placebo in a randomized clinical trial...
  41. ncbi request reprint Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis
    Chen O u Zhang
    Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Urology 61:897-901. 2003
    ..Because little is known about the epidemiology of this disorder, it is unclear whether these factors would also be useful biomarkers for IC in patients from different racial groups and/or geographic locations...
  42. ncbi request reprint Comparison of dry mouth in women treated with extended-release formulations of oxybutynin or tolterodine for overactive bladder
    Robert B Armstrong
    Clinical Affairs, Ortho McNeil Pharma ceutical, Inc, Raritan, NJ 08869, USA
    Int Urol Nephrol 37:247-52. 2005
    ..380). The results of this analysis showed that dry mouth was common with both treatments, but most events were mild; there was no difference in the rate of severe dry mouth or in the rate of withdrawal due to dry mouth...

Research Grants4

  1. Safety and Efficacy of Nerve Rerouting for Treating Neurogenic Bladder in Spina B
    Kenneth M Peters; Fiscal Year: 2010
    ..Dr. Xiao, in China, developed a new procedure to rewire the nerves affecting the bladder, and this project aims to scientifically establish the safety and effectiveness of the surgical procedure. ..
  2. Beaumont Interstitial Cystitis Clinical Research Network
    Kenneth Peters; Fiscal Year: 2007
    ..Adverse events and complications will be monitored. Ancillary studies as agreed upon by the ICCRN will be carried out in conjunction with the clinical trial. ..